Pulmonology
Home Pulmonology
FDA: Insulin Among Drugs Transitioned to Biological Products
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
Triple Therapy Cuts Mortality in Patients With Symptomatic COPD
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
More Americans Recognizing Importance of COVID-19 Safety Measures
Yet many Americans still believe they have little chance of catching the virus
Management of Elective Surgery Reviewed in Setting of COVID-19
Two sets of recommendations relate to management of elective surgery, triage of nonemergent operations
CDC: Modest Decreases Seen in TB Cases, TB-Related Deaths
From 2017 to 2018, 2 and 5 percent declines seen in incident TB and TB-related deaths, respectively
Article Addresses Management of Cancer Care During COVID-19
Patient information should be provided; well visits should be rescheduled, transitioned to telemedicine
Mental Health at Risk for Health Care Workers Treating COVID-19
Nurses, women, frontline health care workers caring for COVID-19 patients at greater mental health risk
Incidence of Subclinical CT Changes High in COVID-19 Cases
Milder severity seen on CT for asymptomatic versus symptomatic Diamond Princess cruise ship cases
Incidence of Tuberculosis High in Children Exposed to the Disease
Preventive therapy effective in most TB-infected children if given before development of active disease
Lopinavir-Ritonavir No Benefit in Adults With Severe COVID-19
No benefit seen in time to clinical improvement, mortality at 28 days compared with standard care alone
